BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2142808)

  • 1. [Neoadjuvant chemotherapy of locally advanced tumors of the bladder: preliminary experience].
    Ruoppolo M; Bellorofonte C; Gritti A; Gozo M; Ferri PM; Tura M; Zaatar C; Tiraboschi B; Morosini D; Dell'Acqua S
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):243-8. PubMed ID: 2142808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy (M-VAC) for locally invasive bladder cancer].
    Kamoto T; Kawakita M; Okabe T; Matsumoto M; Matsuda T; Yoshida O
    Hinyokika Kiyo; 1992 Apr; 38(4):405-11. PubMed ID: 1529813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
    Kuroda M; Kotake T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C; Caro Cebrián C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Rioja Sanz LA
    Arch Esp Urol; 1990; 43 Suppl 2():197-204. PubMed ID: 2096779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant chemotherapy of infiltrating carcinoma of the bladder: our experience].
    Graziotti P; Personeni A; Benzone S; Giannone C; Giardina G; Guizzetti C; Ranieri A; Romano C; Taino R; Lembo A
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):223-9. PubMed ID: 2142805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
    Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].
    Bellmunt Molins J; Ribas A; Albanell J; Lorente Garín JA; de Torres Mateos JA; Morote Robles J; López Palacios MA; Banús Gassol JM; Casado Cobo S; Eres N; Solé Calvo LA
    Arch Esp Urol; 1996 Jun; 49(5):465-72. PubMed ID: 8766083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B; Torelli T; Leidi GL; Corrada P; Bacchioni AM; Ordesi G; Zanitzer L
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-based neoadjuvant chemotherapy for invasive bladder cancer.
    Kadena H; Igawa M; Shigeta M; Nakamoto T; Usui T
    Hiroshima J Med Sci; 1995 Dec; 44(4):129-32. PubMed ID: 8857236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy using methotrexate and cisplatin in locally advanced urothelial cancer of the bladder].
    Pizzocaro G; Piva L; Minervini G; Dormia E; Maggioni A; Mandressi A; Pisani E
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):231-5. PubMed ID: 2142806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
    Rassweiler J; Rüther U; Bäuerle K; Bub P; Jipp P; Eisenberger F
    Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stage T4 bladder cancer. Impact of neoadjuvant chemotherapy on T4b tumors].
    Solsona E; Iborra I; Ricós JV; Monrós JL; Dumont R; Guillem V
    Arch Esp Urol; 1990; 43 Suppl 2():205-8. PubMed ID: 2096780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant systemic chemotherapy with VMC (vinblastine, methotrexate and cisplatin) in locally advanced carcinoma of the bladder].
    Maffezzini M; Rigatti P
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):219-21. PubMed ID: 2142804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
    Stöckle M; Meyenburg W; Wellek S; Voges G; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    Ann Urol (Paris); 1993; 27(1):51-7. PubMed ID: 7682388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.